Value proposition

Explore Toujeo® Max and how it may help your patients. Learn more at toujeopro.com. Intended for US residents only.

This is developed under the direction and financial sponsorship of Sanofi and is intended for U.S. healthcare professionals only.

View full Prescribing Info at https://bit.ly/3o1dj3W

We reserve the right to block users from this page who violate the Rules of Engagement. We reserve the right to remove this page and its contents at any time. Please check often for updates, as we reserve the right, in our sole discretion, to modify these Rules of Engagement at any time. Your use of this LinkedIn page indicates your acceptance of, and any revisions to, these terms.

1. From time to time this page may contain information related to various health and medical conditions and their treatment. Such information is not meant to be a substitute for the advice provided by your doctor. You should not use the information for diagnosing a health problem or disease. You should always consult your doctor.

2. Sanofi can only confirm the accuracy of the information we post on this page and does not verify, approve or endorse information shared by visitors and does not warrant their accuracy. Caution should be used before relying on any particular statements or opinions expressed outside of this page.

3. This is not an interactive or response enabled page. Therefore, commenting, and direct messaging are turned off. To learn more about Toujeo® (insulin glargine), please visit www.toujeopro.com or call 800-981-2491.

4. If you, or someone you know, have possibly experienced a side effect while taking Toujeo® (insulin glargine), please contact us at 1-800-633-1610. You are also encouraged to report side effects of prescription drugs to the FDA. To do so, visit http://www.fda.gov/medwatch or call 1-800-FDA-1088.

MAT-US-2208263-v2.0-01/2023